Rituximab in the treatment of idiopathic thrombocytopenic purpura (ITP)
Author:
Publisher
Springer Science and Business Media LLC
Subject
Hematology,General Medicine
Link
http://link.springer.com/content/pdf/10.1007/s00277-008-0574-9.pdf
Reference14 articles.
1. British Committee for Standards in Haematology (2003) Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematology 120:574–596
2. Coiffer B, Lepage E, Briere J, Henbrecht R, Tilly H, Bouabdallah R et al (2002) CHOP chemotherapy plus Rituximab compared with CHOP alone in elderly patients with diffuse large B-cell lymphoma. N Engl J Med 346:235–242 doi: 10.1056/NEJMoa011795
3. Cooper N, Stasi R, Cunningham- Rundles S et al (2004) The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with immune thrombocytopenic purpura. Br J Haematol 125(2):232 doi: 10.1111/j.1365-2141.2004.04889.x
4. Czuczman MS, Grillo-Lopez AJ, White CA, Saleh M, Gordon L, LoBuuglio AF et al (1999) Treatment of patients with low grade B cell lymphoma with the combination of chimeric anti CD20 monoclonal antibody and CHOP chemotherapy. J Clin Oncol 17:268–276
5. Figueroa M, Gehlsen J, Hammond D et al (1991) Combination chemotherapy in refractory immune thrombocytopenic purpura. Blood 81:3484–3485
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A Case of Primary Refractory Immune Thrombocytopenia: Challenges in Choice of Therapies;Case Reports in Hematology;2018-07-03
2. Profound symptomatic hypogammaglobulinemia: A rare late complication after rituximab treatment for immune thrombocytopenia. Report of 3 cases and systematic review of the literature.;Autoimmunity Reviews;2014-10
3. Long-term follow-up of children with refractory immune thrombocytopenia treated with rituximab;International Journal of Hematology;2014-03-08
4. Frequency of the off-label use of monoclonal antibodies in clinical practice: a systematic review of the literature;Current Medical Research and Opinion;2013-11-12
5. Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia;Blood;2012-06-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3